General Information of the Protein
Protein ID |
PT05756
|
||||
---|---|---|---|---|---|
Protein Name |
Leukotriene B4 receptor 2
|
||||
Secondarily Protein Name |
LTB4 receptor JULF2
Leukotriene B4 receptor BLT2
Seven transmembrane receptor BLTR2
|
||||
Gene Name |
LTB4R2
|
||||
Secondarily Gene Name |
BLT2R
BLTR2
|
||||
Sequence |
MSVCYRPPGNETLLSWKTSRATGTAFLLLAALLGLPGNGFVVWSLAGWRPARGRPLAATLVLHLALADGAVLLLTPLFVAFLTRQAWPLGQAGCKAVYYVCALSMYASVLLTGLLSLQRCLAVTRPFLAPRLRSPALARRLLLAVWLAALLLAVPAAVYRHLWRDRVCQLCHPSPVHAAAHLSLETLTAFVLPFGLMLGCYSVTLARLRGARWGSGRHGARVGRLVSAIVLAFGLLWAPYHAVNLLQAVAALAPPEGALAKLGGAGQAARAGTTALAFFSSSVNPVLYVFTAGDLLPRAGPRFLTRLFEGSGEARGGGRSREGTMELRTTPQLKVVGQGRGNGDPGGGMEKDGPEWDL
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Membrane receptor
>
Family A G protein-coupled receptor
>
Small molecule receptor (family A GPCR)
>
Lipid-like ligand receptor (family A GPCR)
>
Leukotriene receptor
|
||||
Function |
Low-affinity receptor for leukotrienes including leukotriene B4. Mediates chemotaxis of granulocytes and macrophages. The response is mediated via G-proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTB4 > 12-epi-LTB4 > LTB5 > LTB3.
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Cell membrane
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000026 , CHO-K1
Cell Line ID: CL000006 , HEK293
Clinical Information about the Protein
Target 1 ( Leukotriene B4 receptor 2 (LTB4R2) )
Target Type | Clinical trial Target | ||||
---|---|---|---|---|---|
Disease | 4 Target-related Diseases | 4 | |||
1 | Human immunodeficiency virus infection [ICD-11: 1C62] | ||||
2 | Inflammatory bowel disease [ICD-11: DD72] | ||||
3 | Kidney cancer [ICD-11: 2C90.0] | ||||
4 | Asthma [ICD-11: CA23] | ||||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | LTB4 | Phase 2 | |||
2 | Biomed 101 | Phase 1 | |||
Discontinued Drug(s) | 3 Discontinued Drugs | 3 | |||
1 | ONO-4057 | Discontinued in Phase 2 | |||
2 | CP-105696 | Discontinued in Phase 1 | |||
3 | LY-255283 | Terminated |